We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+11.95%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$24.8B
AUM Growth
+$3.92B
(+19%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
7.15%
Top 10 Holdings %
Top 10 Hldgs %
19.71%
Holding
613
New
70
Increased
229
Reduced
209
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$209M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$169M |
| 3 |
CVS Health
CVS
|
+$135M |
| 4 |
Conagra Brands
CAG
|
+$131M |
| 5 |
Ambev
ABEV
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$250M |
| 2 |
Transocean
RIG
|
+$168M |
| 3 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$133M |
| 4 |
Johnson & Johnson
JNJ
|
+$112M |
| 5 |
Capital One
COF
|
+$96.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.31% |
| 2 | Technology | 13.6% |
| 3 | Financials | 12.35% |
| 4 | Consumer Staples | 9.96% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VR
101
DELISTED
Validus Hold Ltd
VR
| $64.7M | 0.26% |
1,604,969
-466,669
| -23% | -$18.2M |
|
|
NBIS
102
Nebius Group N.V.
NBIS
$47.7B
| $63.7M | 0.26% |
1,476,562
-954,165
| -39% | -$37.1M |
|
|
ALTR
103
DELISTED
Altera Corp
ALTR
| $63.6M | 0.26% |
1,954,182
+220,807
| +13% | +$7.39M |
|
104
Huntington Bancshares
HBAN
$35.1B
| $62.2M | 0.25% |
6,444,640
+661,937
| +11% | +$5.95M |
|
|
AET
105
DELISTED
Aetna Inc
AET
| $61.3M | 0.25% |
894,100
-2,300
| -0.3% | -$150K |
|
106
Bausch Health
BHC
$1.65B
| $61.3M | 0.25% |
521,971
+143,154
| +38% | +$15.7M |
|
107
Union Pacific
UNP
$183B
| $60.7M | 0.24% |
722,060
+82,618
| +13% | +$6.54M |
|
108
Mondelez International
MDLZ
$77.7B
| $59.8M | 0.24% |
1,695,259
+30,570
| +2% | +$1.02M |
|
|
ROSE
109
DELISTED
ROSETTA RESOURCES INC
ROSE
| $59.3M | 0.24% |
1,233,389
+1,220,789
| +9,689% | +$65.8M |
|
|
SLXP
110
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $59.1M | 0.24% |
656,872
+206,937
| +46% | +$16.5M |
|
111
Home Depot
HD
$332B
| $58.2M | 0.23% |
706,779
+73,870
| +12% | +$5.76M |
|
112
Truist Financial
TFC
$63.2B
| $57.7M | 0.23% |
1,546,266
+438,845
| +40% | +$15.2M |
|
113
Chevron
CVX
$388B
| $57.3M | 0.23% |
459,061
-121,707
| -21% | -$14.7M |
|
114
J.M. Smucker
SJM
$12.6B
| $56.4M | 0.23% |
543,893
-7,779
| -1% | -$825K |
|
115
Procter & Gamble
PG
$343B
| $55.6M | 0.22% |
682,661
+289,131
| +73% | +$23.6M |
|
116
Danaher
DHR
$135B
| $55.6M | 0.22% |
1,070,639
+60,667
| +6% | +$2.98M |
|
|
HOUS
117
DELISTED
Anywhere Real Estate
HOUS
| $55.4M | 0.22% |
1,120,528
+123,766
| +12% | +$5.6M |
|
118
Masco
MAS
$16B
| $54.5M | 0.22% |
2,725,229
+1,384,210
| +103% | +$25.7M |
|
119
Dr. Reddy's Laboratories
RDY
$9.82B
| $54.4M | 0.22% |
6,634,360
+1,166,080
| +21% | +$9.23M |
|
120
Huazhu Hotels Group
HTHT
$12.4B
| $54.2M | 0.22% |
7,114,712
-272,720
| -4% | -$1.65M |
|
121
Coca-Cola
KO
$354B
| $53.6M | 0.22% |
1,296,845
-4,724
| -0.4% | -$186K |
|
|
URS
122
DELISTED
URS CORP
URS
| $53.1M | 0.21% |
+1,002,048
| New | +$52.7M |
|
123
Agilent Technologies
A
$39.1B
| $52.7M | 0.21% |
+1,287,309
| New | +$48.9M |
|
124
TAL Education Group
TAL
$5.71B
| $51.3M | 0.21% |
13,994,154
-2,406,600
| -15% | -$7.41M |
|
125
Pentair
PNR
$10.2B
| $50.8M | 0.2% |
974,626
+53,291
| +6% | +$2.48M |
|
Similar funds
Fidelity International's Q4 2013 Portfolio in Review
As of Q4 2013, Fidelity International held 613 positions worth $24.8B, up 19% from $20.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fidelity International deployed $1.77B of net new capital in Q4 2013, opening 70 new positions and adding to 229 existing holdings. Its largest new stake was Conagra Brands: 5,248,985 shares worth $138M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Merck, an estimated $250M trimmed.
- Fidelity International's largest Q4 2013 buy was Conagra Brands: 5,248,985 shares worth $138M.
- Fidelity International added most to AbbVie in Q4 2013, an estimated $209M increase.
- Fidelity International's biggest Q4 2013 reduction was Merck, cutting an estimated $250M.
- Fidelity International fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $133M.
- Fidelity International's ten largest holdings make up 20% of its $24.8B portfolio in Q4 2013.
- Fidelity International opened 70 new positions and closed 84 in Q4 2013.
- Fidelity International's portfolio value rose 19% quarter-over-quarter to $24.8B.
Based on Fidelity International's 13F filing for Q4 2013, filed 13 Feb 2014.